Last reviewed · How we verify

NCT03529552: BIORELICA

Evaluation After Reconstruction of the Anterior Cruciate Ligament of the Knee Using the Bioresorbable Interference Screw (SMS): Resorbability, Per- and Post-operative Complications and Articular Functional Recovery.

Terminated NA Last updated 5 August 2020
What this trial tests

NA trial testing Anterior Cruciate Ligament Reconstruction in Anterior Cruciate Ligament Rupture in 40 participants. Terminated before completion.

Timeline
17 September 2018
Primary endpoint
24 April 2019
24 April 2019

Quick facts

Lead sponsorCentre Hospitalier Universitaire de Nīmes
PhaseNA
StatusTerminated
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment40
Start date17 September 2018
Primary completion24 April 2019
Estimated completion24 April 2019
Sites3 locations across France

Drugs / interventions tested

Conditions studied

Sponsor

Centre Hospitalier Universitaire de Nīmes

Who can join

18 and older, any sex, with Anterior Cruciate Ligament Rupture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators will evaluate the benefit of a new bioresorbable screw for repair of anterior cruciate ligament over 3 years.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Research progress and clinical application of all-inside reconstruction techniques: narrative review.
    Jiang Y, Qian D, Lu Q, Cao Y, et al · · 2025 · cited 1× · PMID 41019127 · DOI 10.3389/fsurg.2025.1644737

Verify or expand the search:

Other trials of Anterior Cruciate Ligament Reconstruction

Trials testing the same drug.

Other recruiting trials for Anterior Cruciate Ligament Rupture

Currently open trials in the same condition.

Other Centre Hospitalier Universitaire de Nīmes trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03529552.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing